This article provides educational information about AFFF firefighting foam litigation and PFAS exposure. It is not legal advice and does not create an attorney-client relationship. Consult with a qualified attorney regarding your specific situation.
Understanding AFFF and PFAS
Aqueous film-forming foam, commonly called AFFF, is firefighting foam used to extinguish petroleum-based fires at airports, military bases, and fire training facilities. AFFF contains per- and polyfluoroalkyl substances, synthetic chemicals known as PFAS or forever chemicals. These chemicals do not break down in the environment or human body, accumulating over time. Firefighters, military personnel, and others exposed to AFFF during training or firefighting operations have developed serious cancers linked to PFAS exposure. Manufacturers including 3M and DuPont allegedly knew AFFF contained dangerous chemicals but failed to warn users about cancer risks.
PFAS chemicals were developed in the mid-20th century for their unique properties including resistance to heat, water, and oil. These same properties that make PFAS effective in firefighting foam also make them persistent in the environment and in human bodies. Once PFAS enters your body, it accumulates rather than being metabolized and eliminated like most chemicals.
The AFFF litigation alleges manufacturers knew PFAS accumulated in human bodies and could cause serious health problems including cancer, yet marketed products without adequate warnings. Firefighters trusted their equipment manufacturers to provide safe gear and were not warned they were being exposed to carcinogens every time they used firefighting foam.
Thousands of firefighters, military servicemembers, and others exposed to AFFF have filed lawsuits after developing cancers they believe resulted from PFAS exposure. The litigation seeks to hold manufacturers accountable for decades of exposing firefighters to dangerous chemicals without warning.
Who Is at Risk from AFFF Exposure
Certain occupations and situations created particularly high AFFF and PFAS exposure.
Firefighters using AFFF for training or actual firefighting experienced direct exposure through skin contact and inhalation. Fire training exercises often involved repeated AFFF use in controlled environments where firefighters were soaked in foam. Actual firefighting operations using AFFF created similar exposures. Civilian municipal firefighters, airport firefighters, and industrial firefighters all used AFFF.
Military personnel at bases where AFFF was used for training and firefighting faced extensive exposure. Military firefighters trained with AFFF regularly. Servicemembers at airbases and on aircraft carriers where AFFF was used for fire suppression also experienced exposure. Military installations used AFFF for decades before PFAS risks became widely known.
Air Force personnel at air bases with AFFF fire suppression systems experienced exposure from system testing, maintenance, and actual use. Hangars and aircraft areas often used AFFF systems.
Navy personnel on aircraft carriers and at naval air stations used AFFF for firefighting and training. Shipboard firefighting training involved AFFF use in confined spaces.
Army and Marine personnel at bases with airfields or fuel storage facilities where AFFF was used faced exposure risks.
Airport workers including airport firefighters and ground crew at commercial and military airports used or were near AFFF use. Airport firefighters trained regularly with AFFF.
Chemical plant workers at facilities manufacturing AFFF or PFAS chemicals experienced occupational exposure to raw PFAS chemicals and finished foam products.
Residents near military bases, airports, or fire training facilities where AFFF contaminated groundwater faced environmental exposure. PFAS from AFFF use seeped into soil and groundwater, contaminating drinking water supplies near bases and airports.
Cancers Linked to PFAS Exposure
Scientific research has identified several cancer types associated with PFAS exposure.
Kidney cancer, also called renal cell carcinoma, has shown strong associations with PFAS exposure in epidemiological studies. Studies of communities with PFAS-contaminated drinking water found elevated kidney cancer rates. Occupational studies of workers exposed to PFAS also showed kidney cancer associations.
Testicular cancer rates were elevated in communities and workers with high PFAS exposure. Testicular germ cell tumors, the most common testicular cancer type in young men, showed particularly strong associations.
Prostate cancer has been linked to PFAS in some studies, though evidence is still developing. Firefighters have elevated prostate cancer rates that may be related to multiple occupational exposures including PFAS.
Thyroid cancer associations with PFAS have emerged from studies of exposed communities. The thyroid accumulates PFAS, potentially leading to cancer development.
Bladder cancer has shown associations with PFAS in some occupational studies. Firefighters experience elevated bladder cancer rates.
Pancreatic cancer, while rare, has shown possible associations with PFAS in some research. More study is needed to confirm this connection.
Liver cancer associations are being investigated as PFAS accumulates in liver tissue. Animal studies show liver effects from PFAS exposure.
Other conditions beyond cancer have been linked to PFAS including thyroid disease, ulcerative colitis, high cholesterol, and pregnancy complications. While litigation primarily focuses on cancer, these other health effects demonstrate PFAS toxicity.
Evidence of Manufacturer Knowledge
Discovery in AFFF litigation has revealed significant evidence about manufacturer knowledge of PFAS dangers.
Internal documents from 3M dating back decades show company scientists were aware PFAS accumulated in human blood and did not break down in the environment. Documents from the 1970s and 1980s show awareness that PFAS was spreading globally and accumulating in wildlife and humans.
Animal studies conducted by manufacturers showed tumors and other health effects in PFAS-exposed animals. These studies provided warnings about potential human health risks that were not adequately shared with product users.
Worker health monitoring at manufacturing facilities revealed elevated PFAS blood levels in workers. Some facilities tracked worker health and were aware of PFAS bioaccumulation in employees.
Communications with EPA and military showed manufacturers provided some health information to regulators and customers while continuing to market products. The extent and timing of disclosures are key litigation issues.
Decisions to phase out certain PFAS chemicals show manufacturers recognized problems. 3M stopped producing certain PFAS chemicals in early 2000s, and DuPont phased out PFOA production. These decisions came after decades of production and use, during which firefighters were exposed without adequate warnings.
Development of PFAS-free foam alternatives demonstrates that manufacturers could have developed safer products earlier. Some manufacturers now produce fluorine-free foams that do not contain PFAS, raising questions about why these alternatives were not developed sooner.
Building Your AFFF Case
Proving AFFF exposure caused your cancer requires comprehensive evidence.
Occupational history documentation establishes your exposure to AFFF. Employment records, training records, and duty assignments prove you worked in positions involving AFFF use. Fire department records, military service records, and employer documentation support exposure proof.
Exposure details including how often you used AFFF, over what time period, in what capacity, and what protective equipment was used help establish exposure levels. Firefighter training records may document specific AFFF training exercises.
Witness testimony from coworkers, fellow firefighters, or military colleagues can corroborate AFFF use in your occupation. Others who trained or worked with you can verify exposure.
Blood testing for PFAS shows current PFAS levels in your blood. While blood testing does not prove historical exposure levels or causation, elevated PFAS compared to general population supports exposure claims.
Medical records document your cancer diagnosis, type, stage, treatment, and prognosis. Oncology records must clearly establish cancer diagnosis.
Medical causation experts prove AFFF exposure caused your cancer. Oncologists, toxicologists, and occupational medicine physicians review exposure history and medical records, research scientific literature, and provide causation opinions.
Regulatory and scientific literature about PFAS health effects supports causation. Published studies linking PFAS to specific cancers strengthen claims.
Differential diagnosis evidence excludes other cancer causes. Experts address family history, other exposures, lifestyle factors, and medical conditions to show AFFF exposure is the probable cause.
Timeline evidence showing when exposure occurred, duration before diagnosis, and latency periods supports causation. Cancer typically requires years to develop after initial exposure.
The AFFF Litigation Process
AFFF litigation is proceeding as a major multidistrict litigation.
Federal MDL consolidation brought thousands of AFFF cases before a single South Carolina federal judge for coordinated proceedings. The MDL includes claims by firefighters, military personnel, and others exposed to AFFF.
Bellwether trial selection identifies representative cases for trial testing key legal and factual issues. Trial outcomes inform settlement negotiations and help parties evaluate case values.
Discovery battles have focused on manufacturer knowledge, scientific evidence of causation, and scope of PFAS contamination. Extensive document production and expert discovery are ongoing.
Personal injury claims by individual firefighters and military members diagnosed with cancer form the bulk of the MDL. These claims seek damages for medical expenses, lost wages, pain and suffering, and other harms.
Municipal water contamination claims by cities and water districts seek cleanup costs and damages from PFAS groundwater contamination near military bases and airports where AFFF was used.
Environmental remediation claims by military and property owners address cleanup of PFAS-contaminated soil and groundwater.
The litigation includes multiple defendants including 3M, DuPont, and other PFAS manufacturers. Different defendants face claims based on their specific products and knowledge.
Damages in AFFF Cancer Cases
AFFF litigation seeks compensation for substantial harms.
Medical expenses include cancer treatment costs like surgery, chemotherapy, radiation, immunotherapy, hospitalizations, medications, ongoing monitoring, and future treatment. Cancer treatment creates significant medical expenses.
Lost wages compensate for income lost during treatment. Cancer treatment requires extended time away from work.
Lost earning capacity applies when cancer prevents returning to firefighting or military careers. Many firefighters and servicemembers face early retirement due to cancer, reducing lifetime earnings.
Pain and suffering recognizes physical pain from cancer and treatment. Chemotherapy, surgery, and disease progression cause severe pain.
Emotional distress addresses psychological impacts of cancer diagnosis and treatment. Cancer causes anxiety, depression, and emotional trauma.
Loss of enjoyment compensates for inability to participate in activities. Cancer prevents recreation, physical activities, and normal life enjoyment.
Career loss damages recognize that firefighters and military members often cannot return to their careers after cancer diagnosis and treatment. Losing careers they were passionate about creates significant non-economic harm.
Shortened life expectancy damages apply when cancer reduces life expectancy. Some PFAS-linked cancers carry high mortality rates.
Wrongful death damages apply when cancer causes death. Families recover funeral costs, loss of support, loss of companionship, and related damages.
Punitive damages for corporate misconduct may be available if evidence shows manufacturers knew PFAS caused cancer but concealed risks. Punitive damages punish wrongful conduct and deter future misconduct.
Scientific Evidence and Causation
AFFF litigation depends on scientific evidence linking PFAS to cancer.
Epidemiological studies of PFAS-exposed communities provide key human health data. Studies of communities near PFAS manufacturing plants with contaminated drinking water found elevated cancer rates.
Occupational studies of workers exposed to PFAS show health effects from workplace exposure. These studies help establish dose-response relationships.
Animal studies demonstrate biological mechanisms for PFAS carcinogenicity. Studies showing tumors in PFAS-exposed animals support human causation arguments.
Biomonitoring data showing PFAS accumulation in human blood demonstrates widespread exposure and bioaccumulation.
Mechanistic studies investigating how PFAS causes cancer identify potential mechanisms including hormone disruption, immune system effects, and cellular damage.
General causation proves PFAS can cause specific cancer types in humans. Specific causation proves PFAS caused cancer in individual plaintiffs based on their specific exposure and medical history.
Statute of Limitations Issues
Time limits for AFFF claims vary by state and create filing deadlines.
Discovery rule application means limitations periods often begin when you discover or reasonably should discover that AFFF caused your cancer. Many firefighters did not connect AFFF to cancer until litigation became public.
Diagnosis date may trigger limitations in some jurisdictions. Courts may find cancer diagnosis puts you on notice to investigate causes.
Delayed discovery for cancers diagnosed before AFFF litigation became widely known may extend filing deadlines for some firefighters.
Occupational disease rules in some states provide special limitations periods for work-related diseases like occupational cancers.
Wrongful death limitations are often shorter than personal injury limitations, requiring prompt action after death.
Government immunity issues affect claims against military or government employers. Federal Tort Claims Act and state immunity laws create special rules for claims against government entities.
When to Seek Legal Help
AFFF cancer claims require specialized expertise.
Warning signs requiring consultation include cancer diagnosis after firefighting or military careers involving AFFF exposure, learning about AFFF litigation and potential PFAS connection to your cancer, elevated PFAS blood levels, or wanting to understand legal options after diagnosis.
Attorney evaluation determines case viability. AFFF attorneys assess occupational history, exposure proof, medical records, and causation evidence.
Contingency representation provides access without upfront costs. AFFF attorneys typically work on contingency.
Time sensitivity requires prompt action. Statutes of limitations make early consultation important.
Documentation gathering of employment records, training records, medical records, and blood testing results helps case evaluation.
This educational article provides general information about AFFF litigation and is not intended as legal advice for any specific situation. AFFF litigation varies by jurisdiction. Firefighters and military personnel diagnosed with cancer after AFFF exposure should consult with qualified attorneys experienced in AFFF litigation who can evaluate their specific situations and provide personalized legal guidance.